Highlights

Share

Program Content

Activities

  • ClinicalThought: ART Resistance
    ART Resistance: New Data From EACS 2021
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 23, 2021

    Expires: November 22, 2022

  • ClinicalThought: BIC/FTC/TAF Rapid ART
    BIC/FTC/TAF for Rapid Initiation of ART: New Data From EACS 2021
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 01, 2021

    Expires: November 30, 2022

  • Audio Recap: EACS 2021
    Key Studies Influencing My Practice Following EACS 2021—Audio Recap
    Conference Coverage
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 30, 2021

    Expires: November 29, 2022

  • Slides: EACS 2021
    Key Studies Influencing My Practice Following EACS 2021
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 15, 2021

    Expires: November 14, 2022

Activities

DOR in Tx-Naive Patients
DRIVE-FORWARD and DRIVE-AHEAD: Safety and Efficacy of Doravirine in Treatment-Naive Adults at 4 Yr
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 03, 2021

Expires: November 02, 2022

LA CAB + RPV: Outcomes by BMI
Combined Analysis of ATLAS, FLAIR, ATLAS-2M: Efficacy and Safety of Switch to LA CAB + RPV by BMI Class
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 05, 2021

Expires: November 04, 2022

MAVMET
MAVMET: Maraviroc ± Metformin for the Treatment of NAFLD in Virologically Suppressed Adults With HIV
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 03, 2021

Expires: November 02, 2022

Lenacapavir Resistance
CAPELLA: Resistance Analysis in Highly Treatment–Experienced Patients Receiving LA Lenacapavir
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 05, 2021

Expires: November 04, 2022

Protocol 011: Week 144
Protocol 011 at Wk 144: Islatravir + Doravirine in Treatment-Naive Persons With HIV
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 03, 2021

Expires: November 02, 2022

SOLAR 3D: Wk 48 Results
SOLAR 3D: Wk 48 Results of Switching to DTG/3TC From Suppressive 3- or 4-Drug ART in PWH With M184V/I Mutations and Virologic Failure
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 02, 2021

Expires: November 01, 2022

TANGO IL-6 Study
TANGO: Associations Between IL-6 and HIV-1 RNA Levels After Switch to DTG/3TC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 04, 2021

Expires: November 03, 2022

CARISEL Interim Results
CARISEL Interim Results: Acceptability, Appropriateness, Feasibility, Barriers, and Facilitators of LA CAB + RPV
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 02, 2021

Expires: November 01, 2022

IMEA 055 FAST: Rapid BIC/FTC/TAF
IMEA 055 FAST: BIC/FTC/TAF for Rapid Initiation of ART in Test-and-Treat Model
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 02, 2021

Expires: November 01, 2022

ANRS Prévenir: Renal Safety
ANRS Prévenir: Renal Safety of Different TDF/FTC Dosing Regimens for HIV PrEP
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp.

ViiV Healthcare